Onglyza And Pancreatic Cancer

Side Effect: Cancer

Lawsuits over the diabetes drug Onglyza have been filed across the country due to the complications the drug has been causing. One potentially fatal complication is pancreatic cancer. Pancreatic cancer is a particularly dangerous form of cancer due to its quiet nature. Because the disease is practically asymptomatic, detection generally does not occur until it is too late.

Onglyza Causes Abnormal Beta Cells

The biology behind this issue stems from an increase in the number and size of beta cells in the pancreas that can be caused by DPP-4 drugs. Beta cells are the cells responsible for the production of insulin. In patients with Type 2 diabetes, these cells tend to lose their capacity to produce insulin. The increase in the beta cells is not ostensibly problematic, since these cells are essential for insulin production. However, DPP-4 drugs such as Onglyza tend to cause production of abnormal beta cells that can become cancerous. Because of this effect, the U.S. Food and Drug Administration has ordered the manufacturers of Onglyza to provide a warning of the risk of pancreatic cancer on the drug's label.

Seek Justice For What You've Been Through

If you or someone you know has suffered from pancreatic cancer or other serious side effects after using Onglyza, you may be able to take legal action. Filing an Onglyza lawsuit may not fix the damage, but it can help to alleviate the physical, emotional and financial losses felt as a result of using Onglyza. At Reich & Binstock, we are here to help. Contact our Houston lawyers for a free and confidential case evaluation. Call 713-352-7883 or 877-643-3099 toll free or complete the contact form on this website.